Shukui Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shukui Zhou has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Qiang Fu
Department of Urology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
9 shared publications Kaile Zhang
Department of Urology, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, China
5 shared publicationsQingsong Zou
Department of Urology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Eastern Institute of Urologic Reconstruction, Shanghai Jiao Tong University, 200233 Shanghai, China
4 shared publicationsWeixin Zhao
Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine Winston-Salem, NC 27157, USA
4 shared publications- Guo Gao
School of Automation and Intelligent Sensing Shanghai Jiao Tong University Shanghai China
3 shared publications - Kaile Zhang
North Florida Research and Education Center, University of Florida, Quincy, USA
3 shared publications
Latest Publications
- 1 November 2020
- Published by Elsevier in Acta Biomaterialia
- Vol. 117, 156-166
Use of bioactive extracellular matrix fragments as a urethral bulking agent to treat stress urinary incontinence
- 1 November 2020
- Published by Elsevier in Acta Biomaterialia
- Vol. 117, 156-166
Use of bioactive extracellular matrix fragments as a urethral bulking agent to treat stress urinary incontinence
- Open Access
- 10 February 2020
- Published by Wiley in Stem Cells International
- Vol. 2020, 1-12
The Fabrication and Evaluation of a Potential Biomaterial Produced with Stem Cell Sheet Technology for Future Regenerative Medicine
To date, the decellularized scaffold has been widely explored as a source of biological scaffolds for regenerative medicine. However, the acellular matrix derived from natural tissues and organs has a lot of defects, including the limited amount of autogenous tissue and surgical complication such as risk of blood loss, wound infection, pain, shock, and functional damage in the donor part of the body. In this study, we prepared acellular matrix using adipose-derived stem cell (ADSC) sheets and evaluate the cellular compatibility and immunoreactivity. The ADSC sheets were fabricated and subsequently decellularized using repeated freeze-thaw, Triton X-100 and SDS decellularization. Oral mucosal epithelial cells were seeded onto the decellularized ADSC sheets to evaluate the cell replantation ability, and silk fibroin was used as the control. Then, acellular matrix was transplanted onto subcutaneous tissue for 1 week or 3 weeks; H&E staining and immunohistochemical analysis of CD68 expression and quantitative real-time PCR (qPCR) were performed to evaluate the immunogenicity and biocompatibility. The ADSC sheet-derived ECM scaffolds preserved the three-dimensional architecture of ECM and retained the cytokines by Triton X-100 decellularization protocols. Compared with silk fibroin in vitro, the oral mucosal epithelial cells survived better on the decellularized ADSC sheets with an intact and consecutive epidermal cellular layer. Compared with porcine small intestinal submucosa (SIS) in vivo, the homogeneous decellularized ADSC sheets had less monocyte-macrophage infiltrating in vivo implantation. During 3 weeks after transplantation, the mRNA expression of cytokines, such as IL-4/IL-10, was obviously higher in decellularized ADSC sheets than that of porcine SIS. A Triton X-100 method can achieve effective cell removal, retain major ECM components, and preserve the ultrastructure of ADSC sheets. The decellularized ADSC sheets possess good recellularization capacity and excellent biocompatibility. This study demonstrated the potential suitability of utilizing acellular matrix from ADSC sheets for soft tissue regeneration and repair.
- 10 February 2020
- Published by Wiley in Stem Cells International
- Vol. 2020, 1-12
Open AccessThe Fabrication and Evaluation of a Potential Biomaterial Produced with Stem Cell Sheet Technology for Future Regenerative Medicine
To date, the decellularized scaffold has been widely explored as a source of biological scaffolds for regenerative medicine. However, the acellular matrix derived from natural tissues and organs has a lot of defects, including the limited amount of autogenous tissue and surgical complication such as risk of blood loss, wound infection, pain, shock, and functional damage in the donor part of the body. In this study, we prepared acellular matrix using adipose-derived stem cell (ADSC) sheets and evaluate the cellular compatibility and immunoreactivity. The ADSC sheets were fabricated and subsequently decellularized using repeated freeze-thaw, Triton X-100 and SDS decellularization. Oral mucosal epithelial cells were seeded onto the decellularized ADSC sheets to evaluate the cell replantation ability, and silk fibroin was used as the control. Then, acellular matrix was transplanted onto subcutaneous tissue for 1 week or 3 weeks; H&E staining and immunohistochemical analysis of CD68 expression and quantitative real-time PCR (qPCR) were performed to evaluate the immunogenicity and biocompatibility. The ADSC sheet-derived ECM scaffolds preserved the three-dimensional architecture of ECM and retained the cytokines by Triton X-100 decellularization protocols. Compared with silk fibroin in vitro, the oral mucosal epithelial cells survived better on the decellularized ADSC sheets with an intact and consecutive epidermal cellular layer. Compared with porcine small intestinal submucosa (SIS) in vivo, the homogeneous decellularized ADSC sheets had less monocyte-macrophage infiltrating in vivo implantation. During 3 weeks after transplantation, the mRNA expression of cytokines, such as IL-4/IL-10, was obviously higher in decellularized ADSC sheets than that of porcine SIS. A Triton X-100 method can achieve effective cell removal, retain major ECM components, and preserve the ultrastructure of ADSC sheets. The decellularized ADSC sheets possess good recellularization capacity and excellent biocompatibility. This study demonstrated the potential suitability of utilizing acellular matrix from ADSC sheets for soft tissue regeneration and repair.
- 1 February 2019
- Published by Elsevier in Acta Biomaterialia
- Vol. 85, 131-141
Bioengineered bladder patches constructed from multilayered adipose-derived stem cell sheets for bladder regeneration
- 1 February 2019
- Published by Elsevier in Acta Biomaterialia
- Vol. 85, 131-141
Bioengineered bladder patches constructed from multilayered adipose-derived stem cell sheets for bladder regeneration
- 1 May 2018
- Published by American Scientific Publishers in Journal of Biomaterials and Tissue Engineering
- Vol. 8 (5) , 691-697
The Effect of Different Concentrations of L-Ascorbic Acid on the Generation of Adipose-Derived Stem Cell Sheets
Adipose-derived stem cells (ADSCs), which are capable of self-renewal and multi-lineage differentiation, have most often been used in cell sheet engineering. L-ascorbic acid (LAA) plays an important role in the fabrication of the ADSCs cell sheet, but the optimal concentration of LAA to generate the ADSCs cell sheet and to regulate the secretion of extracellular matrix (ECM) components has not been well-studied. By supplementing different concentrations of LAA in the culture medium, we explored the effect of various LAA concentrations on adipose-derived stem cell sheet formation and detected the expression of type I collagen and fibronectin at both the gene and protein levels, in addition to observing the speed and thickness of cell sheet formation. After two weeks of cultivation, we demonstrated that LAA in the concentration range of 0–100 μg/mL had no significant influence on the proliferation of ADSCs, but it could significantly enhance ADSCs cell sheet formation with abundant extracellular matrix deposition in a dose-dependent manner. Our results also showed that type I collagen was the principal component of the cell sheet induced by LAA stimulation, and the thickness could reach approximately 100 μm at a concentration of 100 μg/mL. We concluded that the optimal dose of LAA can provide a convenient and efficient approach to promote cell sheet formation for ASDCs mainly by increasing the secretion of type I collagen, and this information could be useful for researchers to optimize cell sheet characteristics for tissue engineering experiments.
- 1 May 2018
- Published by American Scientific Publishers in Journal of Biomaterials and Tissue Engineering
- Vol. 8 (5) , 691-697
The Effect of Different Concentrations of L-Ascorbic Acid on the Generation of Adipose-Derived Stem Cell Sheets
Adipose-derived stem cells (ADSCs), which are capable of self-renewal and multi-lineage differentiation, have most often been used in cell sheet engineering. L-ascorbic acid (LAA) plays an important role in the fabrication of the ADSCs cell sheet, but the optimal concentration of LAA to generate the ADSCs cell sheet and to regulate the secretion of extracellular matrix (ECM) components has not been well-studied. By supplementing different concentrations of LAA in the culture medium, we explored the effect of various LAA concentrations on adipose-derived stem cell sheet formation and detected the expression of type I collagen and fibronectin at both the gene and protein levels, in addition to observing the speed and thickness of cell sheet formation. After two weeks of cultivation, we demonstrated that LAA in the concentration range of 0–100 μg/mL had no significant influence on the proliferation of ADSCs, but it could significantly enhance ADSCs cell sheet formation with abundant extracellular matrix deposition in a dose-dependent manner. Our results also showed that type I collagen was the principal component of the cell sheet induced by LAA stimulation, and the thickness could reach approximately 100 μm at a concentration of 100 μg/mL. We concluded that the optimal dose of LAA can provide a convenient and efficient approach to promote cell sheet formation for ASDCs mainly by increasing the secretion of type I collagen, and this information could be useful for researchers to optimize cell sheet characteristics for tissue engineering experiments.
- 1 October 2017
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 198 (4) , 869-874
The Immediate Management of Pelvic Fracture Urethral Injury—Endoscopic Realignment or Cystostomy?
We determined whether endoscopic realignment or cystostomy would provide the best immediate management of pelvic fracture urethral injury. We retrospectively reviewed the records of 590 patients with pelvic fracture urethral injury. Of the patients 522 were included in analysis due to strict criteria, including 129 in the endoscopic realignment group and 393 in the cystostomy group. Data on stricture formation and length, intervention technique and long-term functional outcomes were analyzed. In the endoscopic realignment group stricture developed in 111 patients (83%) at a mean of 23.5 months, which is longer than the 7.6 months reported in the cystostomy group (p <0.05). Mean stricture length was 3.2 cm in the realignment group and 3.7 cm in the cystostomy group (p <0.05). Internal urethrotomy was performed in 21 patients (19%) treated with realignment vs 18 (5%) treated with cystostomy (p <0.05). Further repair was accomplished via simple perineal anastomosis in 57 patients (51%) with realignment and 138 (35%) with cystostomy (p <0.05). Ancillary procedures such as corporeal splitting, inferior pubectomy and crural rerouting were necessary in 14 (13%), 14 (13%) and 5 patients (4%) in the endoscopic realignment group, and in 94 (24%), 100 (25%) and 43 (11%), respectively, in the cystostomy group (all p 0.05). Endoscopic realignment may reduce stricture formation and length, and facilitate urethroplasty. However, endoscopic realignment is also associated with a prolonged clinical course for recurrence.
- 1 October 2017
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 198 (4) , 869-874
The Immediate Management of Pelvic Fracture Urethral Injury—Endoscopic Realignment or Cystostomy?
We determined whether endoscopic realignment or cystostomy would provide the best immediate management of pelvic fracture urethral injury. We retrospectively reviewed the records of 590 patients with pelvic fracture urethral injury. Of the patients 522 were included in analysis due to strict criteria, including 129 in the endoscopic realignment group and 393 in the cystostomy group. Data on stricture formation and length, intervention technique and long-term functional outcomes were analyzed. In the endoscopic realignment group stricture developed in 111 patients (83%) at a mean of 23.5 months, which is longer than the 7.6 months reported in the cystostomy group (p <0.05). Mean stricture length was 3.2 cm in the realignment group and 3.7 cm in the cystostomy group (p <0.05). Internal urethrotomy was performed in 21 patients (19%) treated with realignment vs 18 (5%) treated with cystostomy (p <0.05). Further repair was accomplished via simple perineal anastomosis in 57 patients (51%) with realignment and 138 (35%) with cystostomy (p <0.05). Ancillary procedures such as corporeal splitting, inferior pubectomy and crural rerouting were necessary in 14 (13%), 14 (13%) and 5 patients (4%) in the endoscopic realignment group, and in 94 (24%), 100 (25%) and 43 (11%), respectively, in the cystostomy group (all p 0.05). Endoscopic realignment may reduce stricture formation and length, and facilitate urethroplasty. However, endoscopic realignment is also associated with a prolonged clinical course for recurrence.
- Open Access
- 21 February 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , srep42793
Labeling adipose derived stem cell sheet by ultrasmall super-paramagnetic Fe3O4 nanoparticles and magnetic resonance tracking in vivo
Cell sheet therapy has emerged as a potential therapeutic option for reparation and reconstruction of damaged tissues and organs. However, an effective means to assess the fate and distribution of transplanted cell sheets in a serial and noninvasive manner is still lacking. To investigate the feasibility of tracking Adipose derived stem cells (ADSCs) sheetin vivousing ultrasmall super-paramagnetic Fe3O4nanoparticles (USPIO), canine ADSCs were cultured and incubated with USPIO and 0.75 μg/ml Poly-L-Lysine (PLL) for 12 h. Labeling efficiency, cell viability, apoptotic cell rate were assessed to screen the optimum concentrations of USPIO for best labeling ADSCs. The results showed ADSCs were labeled by USPIO at an iron dose of 50 μg/ml for a 12 h incubation time, which can most efficiently mark cells and did not impair the cell survival, self-renewal, and proliferation capacity. USPIO-labeled ADSCs sheets can be easily and clearly detectedin vivoand have persisted for at least 12 weeks. Our experiment confirmed USPIO was feasible forin vivolabeling of the ADSCs sheets with the optimal concentration of 50 μg Fe/ml and the tracing time is no less than 12 weeks.
- 21 February 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , srep42793
Open AccessLabeling adipose derived stem cell sheet by ultrasmall super-paramagnetic Fe3O4 nanoparticles and magnetic resonance tracking in vivo
Cell sheet therapy has emerged as a potential therapeutic option for reparation and reconstruction of damaged tissues and organs. However, an effective means to assess the fate and distribution of transplanted cell sheets in a serial and noninvasive manner is still lacking. To investigate the feasibility of tracking Adipose derived stem cells (ADSCs) sheetin vivousing ultrasmall super-paramagnetic Fe3O4nanoparticles (USPIO), canine ADSCs were cultured and incubated with USPIO and 0.75 μg/ml Poly-L-Lysine (PLL) for 12 h. Labeling efficiency, cell viability, apoptotic cell rate were assessed to screen the optimum concentrations of USPIO for best labeling ADSCs. The results showed ADSCs were labeled by USPIO at an iron dose of 50 μg/ml for a 12 h incubation time, which can most efficiently mark cells and did not impair the cell survival, self-renewal, and proliferation capacity. USPIO-labeled ADSCs sheets can be easily and clearly detectedin vivoand have persisted for at least 12 weeks. Our experiment confirmed USPIO was feasible forin vivolabeling of the ADSCs sheets with the optimal concentration of 50 μg Fe/ml and the tracing time is no less than 12 weeks.
- Open Access
- 1 January 2017
- Published by Ivyspring International Publisher in Theranostics
- Vol. 7 (9) , 2509-2523
Fabrication of Tissue-Engineered Bionic Urethra Using Cell Sheet Technology and Labeling By Ultrasmall Superparamagnetic Iron Oxide for Full-Thickness Urethral Reconstruction
Urethral strictures remain a reconstructive challenge, due to less than satisfactory outcomes and high incidence of stricture recurrence. An “ideal” urethral reconstruction should establish similar architecture and function as the original urethral wall. We fabricated a novel tissue-engineered bionic urethras using cell sheet technology and report their viability in a canine model. Small amounts of oral and adipose tissues were harvested, and adipose-derived stem cells, oral mucosal epithelial cells, and oral mucosal fibroblasts were isolated and used to prepare cell sheets. The cell sheets were hierarchically tubularized to form 3-layer tissue-engineered urethras and labeled by ultrasmall super-paramagnetic iron oxide (USPIO). The constructed tissue-engineered urethras were transplanted subcutaneously for 3 weeks to promote the revascularization and biomechanical strength of the implant. Then, 2 cm length of the tubularized penile urethra was replaced by tissue-engineered bionic urethra. At 3 months of urethral replacement, USPIO-labeled tissue-engineered bionic urethra can be effectively detected by MRI at the transplant site. Histologically, the retrieved bionic urethras still displayed 3 layers, including an epithelial layer, a fibrous layer, and a myoblast layer. Three weeks after subcutaneous transplantation, immunofluorescence analysis showed the density of blood vessels in bionic urethra was significantly increased following the initial establishment of the constructs and was further up-regulated at 3 months after urethral replacement and was close to normal level in urethral tissue. Our study is the first to experimentally demonstrate 3-layer tissue-engineered urethras can be established using cell sheet technology and can promote the regeneration of structural and functional urethras similar to normal urethra.
- 1 January 2017
- Published by Ivyspring International Publisher in Theranostics
- Vol. 7 (9) , 2509-2523
Open AccessFabrication of Tissue-Engineered Bionic Urethra Using Cell Sheet Technology and Labeling By Ultrasmall Superparamagnetic Iron Oxide for Full-Thickness Urethral Reconstruction
Urethral strictures remain a reconstructive challenge, due to less than satisfactory outcomes and high incidence of stricture recurrence. An “ideal” urethral reconstruction should establish similar architecture and function as the original urethral wall. We fabricated a novel tissue-engineered bionic urethras using cell sheet technology and report their viability in a canine model. Small amounts of oral and adipose tissues were harvested, and adipose-derived stem cells, oral mucosal epithelial cells, and oral mucosal fibroblasts were isolated and used to prepare cell sheets. The cell sheets were hierarchically tubularized to form 3-layer tissue-engineered urethras and labeled by ultrasmall super-paramagnetic iron oxide (USPIO). The constructed tissue-engineered urethras were transplanted subcutaneously for 3 weeks to promote the revascularization and biomechanical strength of the implant. Then, 2 cm length of the tubularized penile urethra was replaced by tissue-engineered bionic urethra. At 3 months of urethral replacement, USPIO-labeled tissue-engineered bionic urethra can be effectively detected by MRI at the transplant site. Histologically, the retrieved bionic urethras still displayed 3 layers, including an epithelial layer, a fibrous layer, and a myoblast layer. Three weeks after subcutaneous transplantation, immunofluorescence analysis showed the density of blood vessels in bionic urethra was significantly increased following the initial establishment of the constructs and was further up-regulated at 3 months after urethral replacement and was close to normal level in urethral tissue. Our study is the first to experimentally demonstrate 3-layer tissue-engineered urethras can be established using cell sheet technology and can promote the regeneration of structural and functional urethras similar to normal urethra.
- Open Access
- 19 July 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (7) , 1163
Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate Cancer
Currently there is little effective treatment available for castration resistant prostate cancer, which is responsible for the majority of prostate cancer related deaths. Emerging evidence suggested that cancer stem cells might play an important role in resistance to traditional cancer therapies, and the studies of cancer stem cells (including specific isolation and targeting on those cells) might benefit the discovery of novel treatment of prostate cancer, especially castration resistant disease. In this review, we summarized major biomarkers for prostate cancer stem cells, as well as their functional mechanisms and potential application in clinical diagnosis and treatment of patients.
- 19 July 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (7) , 1163
Open AccessCurrent Stem Cell Biomarkers and Their Functional Mechanisms in Prostate Cancer
Currently there is little effective treatment available for castration resistant prostate cancer, which is responsible for the majority of prostate cancer related deaths. Emerging evidence suggested that cancer stem cells might play an important role in resistance to traditional cancer therapies, and the studies of cancer stem cells (including specific isolation and targeting on those cells) might benefit the discovery of novel treatment of prostate cancer, especially castration resistant disease. In this review, we summarized major biomarkers for prostate cancer stem cells, as well as their functional mechanisms and potential application in clinical diagnosis and treatment of patients.
- 14 June 2016
- Published by S. Karger AG in Urologia Internationalis
- Vol. 97 (4) , 386-391
Etiology and Management of Male Iatrogenic Urethral Stricture: Retrospective Analysis of 172 Cases in a Single Medical Center
Purpose: To investigate the etiology and management of male iatrogenic urethral stricture in China. Methods: The data of 172 patients with iatrogenic urethral stricture who underwent treatment at a high volume reference center in China from January 2008 to February 2014 were analyzed retrospectively. Databases were analyzed to understand the impact of different types of iatrogenic injury on stricture location, length and treatment of urethral strictures, as well as success rates. Results: The most common type of iatrogenic stricture was urethral instrumentations in 80 patients (46.51%). Mean stricture length was 3.3 ± 2.54 cm and the longest strictures were those caused by intravesical instillation. Substitution urethroplasty was the most common intervention and was performed in 60.47% (104/172) of patients. The overall success rate was 85.00% (136/160). Univariable analyses revealed that the type of iatrogenic injury was significantly related to restenosis (p = 0.036), and it is more apt to postoperative restenosis in the type of intravesical instillation than others. Conclusion: Our results showed that urethral instrumentation is the most common etiology of iatrogenic urethral stricture, and most iatrogenic urethral strictures involve the anterior urethra. The different etiologies are closely associated with stricture location, length and the overall prognosis of urethral strictures.
- 14 June 2016
- Published by S. Karger AG in Urologia Internationalis
- Vol. 97 (4) , 386-391
Etiology and Management of Male Iatrogenic Urethral Stricture: Retrospective Analysis of 172 Cases in a Single Medical Center
Purpose: To investigate the etiology and management of male iatrogenic urethral stricture in China. Methods: The data of 172 patients with iatrogenic urethral stricture who underwent treatment at a high volume reference center in China from January 2008 to February 2014 were analyzed retrospectively. Databases were analyzed to understand the impact of different types of iatrogenic injury on stricture location, length and treatment of urethral strictures, as well as success rates. Results: The most common type of iatrogenic stricture was urethral instrumentations in 80 patients (46.51%). Mean stricture length was 3.3 ± 2.54 cm and the longest strictures were those caused by intravesical instillation. Substitution urethroplasty was the most common intervention and was performed in 60.47% (104/172) of patients. The overall success rate was 85.00% (136/160). Univariable analyses revealed that the type of iatrogenic injury was significantly related to restenosis (p = 0.036), and it is more apt to postoperative restenosis in the type of intravesical instillation than others. Conclusion: Our results showed that urethral instrumentation is the most common etiology of iatrogenic urethral stricture, and most iatrogenic urethral strictures involve the anterior urethra. The different etiologies are closely associated with stricture location, length and the overall prognosis of urethral strictures.